Cited 26 time in
Conformation-Enabled Total Syntheses of Ohmyungsamycins A and B and Structural Revision of Ohmyungsamycin B
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Hur, Joonseong | - |
| dc.contributor.author | Jang, Jaebong | - |
| dc.contributor.author | Sim, Jaehoon | - |
| dc.contributor.author | Son, Woo Sung | - |
| dc.contributor.author | Ahn, Hee-Chul | - |
| dc.contributor.author | Kim, Tae Sung | - |
| dc.contributor.author | Shin, Yern-Hyerk | - |
| dc.contributor.author | Lim, Changjin | - |
| dc.contributor.author | Lee, Seungbeom | - |
| dc.contributor.author | An, Hongchan | - |
| dc.contributor.author | Kim, Seok-Ho | - |
| dc.contributor.author | Oh, Dong-Chan | - |
| dc.contributor.author | Jo, Eun-Kyeong | - |
| dc.contributor.author | Jang, Jichan | - |
| dc.contributor.author | Lee, Jeeyeon | - |
| dc.contributor.author | Suh, Young-Ger | - |
| dc.date.accessioned | 2022-12-26T17:04:42Z | - |
| dc.date.available | 2022-12-26T17:04:42Z | - |
| dc.date.issued | 2018-03-12 | - |
| dc.identifier.issn | 1433-7851 | - |
| dc.identifier.issn | 1521-3773 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/11812 | - |
| dc.description.abstract | The first total syntheses of the bioactive cyclo-depsipeptides ohmyungsamycin A and B are described. Key features of our synthesis include the concise preparation of a linear cyclization precursor that consists of N-methyl amides and non-proteinogenic amino acids, and its macrolactamization from a bent conformation. The proposed structure of ohmyungsamycin B was revised based on its synthesis. The cyclic core of the ohmyungsamycins was shown to be responsible for the excellent antituberculosis activity, and ohmyungsamycin variants with truncated chains were evaluated for their biological activity. | - |
| dc.format.extent | 5 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | WILEY-V C H VERLAG GMBH | - |
| dc.title | Conformation-Enabled Total Syntheses of Ohmyungsamycins A and B and Structural Revision of Ohmyungsamycin B | - |
| dc.type | Article | - |
| dc.publisher.location | 독일 | - |
| dc.identifier.doi | 10.1002/anie.201711286 | - |
| dc.identifier.scopusid | 2-s2.0-85042234557 | - |
| dc.identifier.wosid | 000426759900008 | - |
| dc.identifier.bibliographicCitation | ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, v.57, no.12, pp 3069 - 3073 | - |
| dc.citation.title | ANGEWANDTE CHEMIE-INTERNATIONAL EDITION | - |
| dc.citation.volume | 57 | - |
| dc.citation.number | 12 | - |
| dc.citation.startPage | 3069 | - |
| dc.citation.endPage | 3073 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | sci | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Chemistry | - |
| dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
| dc.subject.keywordPlus | CYCLIC-PEPTIDES | - |
| dc.subject.keywordPlus | AMINO-ACIDS | - |
| dc.subject.keywordPlus | CYCLIZATION | - |
| dc.subject.keywordPlus | MACROCYCLIZATION | - |
| dc.subject.keywordPlus | DEPSIPEPTIDES | - |
| dc.subject.keywordPlus | IODOANILINES | - |
| dc.subject.keywordPlus | ANNULATION | - |
| dc.subject.keywordPlus | LYSOBACTIN | - |
| dc.subject.keywordPlus | DISCOVERY | - |
| dc.subject.keywordPlus | SEQUENCE | - |
| dc.subject.keywordAuthor | cyclodepsipeptides | - |
| dc.subject.keywordAuthor | macrolactamization | - |
| dc.subject.keywordAuthor | natural products | - |
| dc.subject.keywordAuthor | structural revision | - |
| dc.subject.keywordAuthor | total synthesis | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
